Shanna K. Nifoussi, Ph.D. - Publications
Affiliations: | Pharmacology | University of Iowa, Iowa City, IA |
Area:
protein phosphatasesYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Nifoussi SK, Ratcliffe NR, Ornstein DL, Kasof G, Strack S, Craig RW. Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells. The Journal of Biological Chemistry. 289: 21950-9. PMID 24939844 DOI: 10.1074/Jbc.M114.587873 | 0.555 | |||
Low-probability matches (unlikely to be authored by this person) | |||||
2012 | Nifoussi SK, Vrana JA, Domina AM, De Biasio A, Gui J, Gregory MA, Hann SR, Craig RW. Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer. Plos One. 7: e47060. PMID 23056582 DOI: 10.1371/Journal.Pone.0047060 | 0.297 | |||
2012 | Oberg EA, Nifoussi SK, Gingras AC, Strack S. Selective proteasomal degradation of the B'β subunit of protein phosphatase 2A by the E3 ubiquitin ligase adaptor Kelch-like 15. The Journal of Biological Chemistry. 287: 43378-89. PMID 23135275 DOI: 10.1074/Jbc.M112.420281 | 0.087 | |||
Hide low-probability matches. |